[ad_1] A first clinical study with a monoclonal antibody targeting alpha-synuclein – or rather, the accumulation of aggregated forms of the protein that could be one of the causes of Parkinson's disease …
Read More »Monoclonal antibody targeting alpha-synuclein. A possible you
